Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
37 studies found for:    Open Studies | "Sweat"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair
Condition: Sweat Gland Diseases
Intervention: Biological: UCB Mesenchymal Stem Cells treatment
2 Not yet recruiting Evaluation of the Sensitivity of a Transdermal Device to Monitor the Sweat Alcohol Concentration
Condition: The Sweat Alcohol Concentration
Interventions: Other: oral dose of alcohol;   Device: alcotest;   Biological: blood samples;   Device: Transdermal monitor
3 Recruiting Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat
Condition: Stability & Variability of Lipid-derived Molecules in Sweat
Interventions: Drug: Ibuprofen;   Other: Physiological induction of sweating;   Drug: Pilocarpine
4 Recruiting Proteomic Analysis of Sweat in Cutaneous Conditions
Condition: Application Site Perspiration
Intervention: Device: Skin Patch
5 Recruiting Single-Treatment, Study of Percutaneous-Temperature Controlled-RF Electrocoagulation on Axilla Tissue
Condition: Sweating Increased Armpits
Intervention: Device: Thermi Radiofrequency
6 Recruiting A Multi-Center Study of the CF Quantum® Sweat Test System
Condition: Cystic Fibrosis
Intervention: Device: Iontophoresis sweat test
7 Recruiting Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis
Condition: Primary Axillary Hyperhidrosis
Interventions: Drug: WO3979;   Drug: WO3970;   Drug: WO3992;   Drug: Placebo (WO3988)
8 Recruiting A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
Condition: Hyperhidrosis
Interventions: Drug: BBI-4000 Concentration 1;   Drug: BBI-4000 Concentration 2;   Drug: BBI-4000 Concentration 3;   Drug: Vehicle (Placebo)
9 Not yet recruiting Summer Weight and Environmental Assessment Trial
Condition: Childhood Obesity
Intervention: Other: n/a - observational study
10 Recruiting Management of Palmar Hyperhidrosis With Hydrogel-based Iontophoresis
Conditions: Hyperhidrosis;   Hyperhidrosis Palmaris et Plantaris
Intervention: Device: Hydrogel electrode-based iontophoresis
11 Not yet recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Conditions: Adenoid Cystic Carcinoma;   Adnexal Carcinoma;   Apocrine Carcinoma;   Eccrine Porocarcinoma;   Extraocular Cutaneous Sebaceous Carcinoma;   Hidradenocarcinoma;   Keratoacanthoma;   Malignant Sweat Gland Neoplasm;   Merkel Cell Carcinoma;   Microcystic Adnexal Carcinoma;   NK-Cell Lymphoma, Unclassifiable;   Non-Melanomatous Lesion;   Paget Disease;   Papillary Adenocarcinoma;   Primary Cutaneous Mucinous Carcinoma;   Refractory Anaplastic Large Cell Lymphoma;   Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma;   Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma;   Refractory Mycosis Fungoides;   Refractory T-Cell Non-Hodgkin Lymphoma;   Sezary Syndrome;   Signet Ring Cell Carcinoma;   Skin Basal Cell Carcinoma;   Skin Basosquamous Cell Carcinoma;   Skin Squamous Cell Carcinoma;   Spiradenocarcinoma;   Squamous Cell Carcinoma of Unknown Primary Origin;   Stage III Skin Cancer;   Stage IV Skin Cancer;   Sweat Gland Carcinoma;   Trichilemmocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Biological: Talimogene Laherparepvec
12 Recruiting Miradry Treatment for Focal Axillary Hyperhidrosis
Condition: Axillary Hyperhidrosis
Intervention: Device: MiraDry ®
13 Recruiting Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis
Condition: Hyperhidrosis
Interventions: Drug: Botox (onabotulinumtoxinA);   Drug: NeuroBloc/Myobloc (rimabotulinumtoxinB);   Drug: NaCl (placebo)
14 Not yet recruiting Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact
Conditions: Psoriasis;   Hidradenitis
Intervention: Other: Observational
15 Recruiting Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Conditions: Anemia;   Fatigue;   Fever;   Lymphadenopathy;   Lymphocytosis;   Night Sweats;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Plasma Cell Myeloma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Plasma Cell Myeloma;   Splenomegaly;   Thrombocytopenia;   Weight Loss
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformin Hydrochloride;   Other: Pharmacological Study;   Drug: Ritonavir
16 Not yet recruiting Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
Conditions: Anemia;   B-Cell Prolymphocytic Leukemia;   Fatigue;   Fever;   Grade 1 Follicular Lymphoma;   Grade 2 Follicular Lymphoma;   Grade 3a Follicular Lymphoma;   Hairy Cell Leukemia;   Lymphadenopathy;   Lymphocytosis;   Lymphoplasmacytic Lymphoma;   Mantle Cell Lymphoma;   Marginal Zone Lymphoma;   Night Sweats;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Small Lymphocytic Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Small Lymphocytic Lymphoma;   Richter Syndrome;   Splenomegaly;   Thrombocytopenia;   Weight Loss
Interventions: Drug: Entospletinib;   Other: Laboratory Biomarker Analysis;   Biological: Obinutuzumab;   Other: Pharmacological Study
17 Recruiting Effects of Sildenafil on CFTR-dependent Ion Transport Activity
Condition: Cystic Fibrosis
Interventions: Drug: Sildenafil;   Drug: Placebo
18 Recruiting The Ohio State University Dermatology Biorepository, Molecular Biology and Genetics of Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Intervention:
19 Recruiting Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Interventions: Drug: Botulinum B Toxin;   Other: Placebo Saline
20 Recruiting Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Intervention: Biological: secukinumab

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.